Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer.

Cancer biology & therapy - 1 Jul 2010

Gao Rui, Price Douglas K, Dahut William L, Reed Eddie, Figg William D

Abstract excerpt

Radiation therapy is a potentially curative, important treatment option in localized prostate cancer. However, at 8 years after radiation therapy, even in the best risk subset of patients, approximately 10% of patients will experience clinical disease recurrence. The identification of molecular m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA-Binding Proteins
Share to DNA Repair
Share to Haplotypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms, Hormone-Dependent

Share to Prognosis

Share to Prostatic Neoplasms

Share to Radiotherapy Dosage

Share to X-ray Repair Cross Complementing Protein 1

Source

Open in PubMed Open full text

Identifiers

PMID: 20495366
DOI: 10.4161/cbt.10.1.12172
PMCID: PMC3040830

Genes

XRCC1
ERCC1
PARP1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20495366-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer.PMID 20495366Read ↗

Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients.Semantic proximity Read ↗

Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer.Semantic proximity Read ↗

Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients.Semantic proximity Read ↗

Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer.Semantic proximity Read ↗

DNA repair gene polymorphisms, tumor control, and treatment toxicity in prostate cancer patients treated with permanent implant prostate brachytherapy.Semantic proximity Read ↗

Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression.Semantic proximity Read ↗

Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.Semantic proximity Read ↗

DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes.Semantic proximity Read ↗

The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genes.Semantic proximity Read ↗

Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene AberrationsSemantic proximity Read ↗

Polymorphisms in DNA-repair genes in a cohort of prostate cancer patients from different areas in Spain: heterogeneity between populations as a confounding factor in association studies.Semantic proximity Read ↗

RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitizationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.